NO20053203L - Kombinasjon av lokale esteranestetika. - Google Patents

Kombinasjon av lokale esteranestetika.

Info

Publication number
NO20053203L
NO20053203L NO20053203A NO20053203A NO20053203L NO 20053203 L NO20053203 L NO 20053203L NO 20053203 A NO20053203 A NO 20053203A NO 20053203 A NO20053203 A NO 20053203A NO 20053203 L NO20053203 L NO 20053203L
Authority
NO
Norway
Prior art keywords
combination
ester anesthetics
action
analgesia
onset
Prior art date
Application number
NO20053203A
Other languages
English (en)
Other versions
NO20053203D0 (no
Inventor
Steven L Shafer
Original Assignee
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leland Stanford Junior filed Critical Univ Leland Stanford Junior
Publication of NO20053203D0 publication Critical patent/NO20053203D0/no
Publication of NO20053203L publication Critical patent/NO20053203L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/625—Salicylic acid; Derivatives thereof having heterocyclic substituents, e.g. 4-salicycloylmorpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Det tilveiebringes preparater og metoder for forbedret lokalanestesi og/eller analgesi der virkningsstarten er hurtig, risikoen for toksisitet er lav og effekten opprettholdes. Mer spesielt tilveiebringes det en kombinasjon av minst to esteranestetika fot administrering til et individ der minst et esteranestetikum gir en hurtig virkningsstart og minst et gir opprettholdt aktivitet. Preparatene ifølge oppfinnelsen er brukbare for å oppnå analgesi og/eller anestesi og er spesielt nyttige ved profylakse og/eller terapi av smerte.
NO20053203A 2002-12-20 2005-06-30 Kombinasjon av lokale esteranestetika. NO20053203L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32731002A 2002-12-20 2002-12-20
PCT/US2003/041219 WO2004058329A2 (en) 2002-12-20 2003-12-18 Ester combination local anesthetic

Publications (2)

Publication Number Publication Date
NO20053203D0 NO20053203D0 (no) 2005-06-30
NO20053203L true NO20053203L (no) 2005-09-19

Family

ID=32680753

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053203A NO20053203L (no) 2002-12-20 2005-06-30 Kombinasjon av lokale esteranestetika.

Country Status (10)

Country Link
EP (1) EP1572218A4 (no)
JP (1) JP2006513224A (no)
KR (1) KR20050085736A (no)
CN (1) CN1729004A (no)
AU (1) AU2003299885A1 (no)
BR (1) BR0317519A (no)
CA (1) CA2507511A1 (no)
MX (1) MXPA05006771A (no)
NO (1) NO20053203L (no)
WO (1) WO2004058329A2 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060062836A1 (en) * 2004-09-21 2006-03-23 Carter Stephen G Methods of device-assisted drug delivery
DK1863469T3 (da) 2005-03-15 2012-03-26 Animal Ethics Pty Ltd Topisk analgesisk sammensætning
ITMI20051633A1 (it) 2005-09-06 2007-03-07 Sint Sa Nuovo uso di una composizione comprendente cloroprocaina hcl nuova composizione comprendente cloroprocaina hcl e metodo per la sua fabbricazione
WO2008011539A2 (en) * 2006-07-19 2008-01-24 Pharmacofore, Inc. Anesthetic compounds
US20080220062A1 (en) * 2006-10-23 2008-09-11 Psivida, Inc. Sustained release of agents for localized pain management
WO2009091546A1 (en) * 2008-01-18 2009-07-23 Pharmacofore, Inc. Anesthetic compounds
ITMI20122120A1 (it) * 2012-12-12 2014-06-13 Sint Sa Composizione farmaceutica a base di cloroprocaina per la somministrazione intratecale ripetuta
ITCR20130004A1 (it) * 2013-02-05 2014-08-06 Vincenzo Vigna Farmaco salvavita
US10117847B2 (en) * 2015-12-04 2018-11-06 Ventis Pharma Extended duration local anesthetic formulation
DE102016215037A1 (de) 2016-08-11 2018-02-15 Franz Baur Federvorrichtung und Verbindungsvorrichtung
JOP20200010A1 (ar) 2017-09-15 2022-10-30 Sintetica S A صيغ موضعية من كلوروبروكائين وطرق استخدامها
WO2019226599A1 (en) * 2018-05-22 2019-11-28 Alkalidx, Inc. Diagnostics and treatments of anesthetic insensitive subjects
JP6886551B1 (ja) * 2020-11-06 2021-06-16 医療法人祥和会 歯科用の局所麻酔液

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
WO1998051290A2 (en) * 1997-05-16 1998-11-19 Children's Medical Center Corporation Local anesthetic formulations comprising a site 1 sodium channel blocker combined with a second active agent
US7273887B1 (en) * 1999-10-22 2007-09-25 Transdermatech, Inc. Topical anesthetic formulation
US6383511B1 (en) * 1999-10-25 2002-05-07 Epicept Corporation Local prevention or amelioration of pain from surgically closed wounds
WO2001054679A2 (en) * 2000-01-27 2001-08-02 Children's Hospital Research Foundation Transdermal composition containing an anesthetic and a vasodilator agent

Also Published As

Publication number Publication date
EP1572218A2 (en) 2005-09-14
MXPA05006771A (es) 2005-09-08
NO20053203D0 (no) 2005-06-30
EP1572218A4 (en) 2007-05-16
WO2004058329A3 (en) 2004-12-29
CN1729004A (zh) 2006-02-01
AU2003299885A1 (en) 2004-07-22
CA2507511A1 (en) 2004-07-15
KR20050085736A (ko) 2005-08-29
JP2006513224A (ja) 2006-04-20
BR0317519A (pt) 2005-11-16
WO2004058329A2 (en) 2004-07-15

Similar Documents

Publication Publication Date Title
NO20053203L (no) Kombinasjon av lokale esteranestetika.
NO20056252L (no) Terapeutiske og profylaktiske metoder for neuromuskulaere lidelser
CY1116463T1 (el) Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης
ATE401874T1 (de) Verabreichung von capsaicinoiden
EP1605956A4 (en) ADMINISTRATION OF CAPSAICINOIDES
NO20073774L (no) Terapeutiske forbindelser for intranasal administrering av ketorolac
NO20056073L (no) Sammensetninger og fremgangsmater til behandling av alvorlig akutt respitatorisk syndrom (SARS)
NO20065368L (no) Terapeutiske blandinger inneholdende minst et pyrrolobenzodiazepinderivat og fludarabin
NO20052272L (no) CCR1-antagonister for behandling av blant annet demylinerene inflamasjonssykdom
MY140576A (en) Cannabinoid active pharmaceutical ingredient for improved dosage forms
CY1107452T1 (el) Διαδερμικη μορφη χορηγησης για τη θεραπεια του συνδρομου ανησυχων ποδιων
IL181826A0 (en) Therapeutic agents targeting the ncca-atp channel and methods of use thereof
NO20050718L (no) Topikal behandling av hudsykdommer
ATE499098T1 (de) Verwendung von parp-1-hemmern
NO20052999L (no) Ny synergistisk kombinasjon omfattende roflumilast og formoterol
DK1303278T3 (da) Kombination af et transdermalt terapeutisk system og et oralt og/eller parenteralt præparat indeholdende dopaminagonister til behandling af dopaminerge sygdomme
CO5690571A2 (es) Combinacion sinergica que comprende roflumilas y (r,r)-formoterol
RS95304A (en) New combination fortreating airway disorders
IS8106A (is) Samsetning makrólíðs og staðdeyfingarlyfs til að meðhöndla húðsjúkdóma
ATE250421T1 (de) Zusammensetzung enthaltend einen extrakt aus perna canaliculus, methylsulfonylmethan und glucosamine und verwendung
RS95204A (en) Combination for the treatment of airway disorders
TW200509922A (en) Methods of therapeutic treatment using amounts of retinoid components
UA41154A (uk) Лікувальний засіб "гермогран-м" на основі олії з зародків пшениці

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application